OR WAIT null SECS
March 02, 2024
Proprietary cell lines offer opportunities for achieving high AAV titers.
March 01, 2024
CordenPharma’s new starter kits are designed to enable effective formulation in the development of mRNA-based therapeutics.
February 02, 2024
Buffers, stabilizers, and cryoprotectants play major roles in cell therapy formulations.
January 05, 2024
MediWound has been granted an additional $6.7 million by the DoD to advance NexoBrid as a non-surgical field care solution for the US military.
December 02, 2023
Preparing for variability and flexible processing are necessary for success.
November 03, 2023
Dujuan Lu, PhD, global leader—E&L, SGS Health Sciences, recommends some key issues that pharma manufacturers should consider when formulating products that require a medical device.
November 02, 2023
There is no such thing as a perfect linker.
November 01, 2023
Sara Fathollahi, PhD, product application specialist at DFE Pharma, makes the case of how excipient suppliers can support the transition from batch to continuous manufacturing.
September 29, 2023
Biologics formulation comes with a unique set of challenges, which can be overcome through innovative strategies and good partnerships.
September 15, 2023
Despite its success, clinical and logistical roadblocks to mRNA cancer vaccine development remain.